Viyash Scientific Appoints Two Additional Directors and Revises ESOP Pool
Viyash Scientific Limited, formerly Sequent Scientific Limited, announced that its Board of Directors, at a meeting held on April 22, 2026, approved the appointment of two additional directors and revised the employee stock option pool for its 2026 scheme.The company approved the appointment of Mr. Amit Jain and Mr. Abhiroop Jayanthi as Additional Directors. Both appointments are designated as Non-Executive, Non-Independent Directors, effective from April 22, 2026, and are liable to retire by rotation, subject to the approval of the shareholders.
New Director Appointments
The board took action to appoint two prominent figures in the industry:Mr. Amit Jain
Mr. Amit Jain, who represents the Carlyle group, was approved to join as an Additional Director. His professional background includes serving as a Partner and Head of Carlyle India Advisors, overseeing the firm’s India operations and private equity team. Mr. Jain specializes in buyout and control investments across the technology, consumer, advanced manufacturing, and industrial sectors. He previously served at Blackstone in India and was a consultant at McKinsey & Company. He currently holds board positions at several Carlyle portfolio companies, including Quest Global, Piramal Healthcare, and VLCC.
Mr. Abhiroop Jayanthi
Similarly, Mr. Abhiroop Jayanthi, representing the Carlyle group, was approved as an Additional Director. Mr. Jayanthi is a Managing Director and member of the Asia Private Equity team at Carlyle, where he advises on investments in India, particularly focusing on healthcare, life sciences, advanced manufacturing, and industrial sectors. With 15 years of experience in private equity, he previously served as a Managing Director at Bain Capital.
ESOP Pool Revision
In addition to the director appointments, the Board approved a revised option pool for the Viyash Scientific Limited Employee Stock Option Scheme 2026 (ESOP 2026). The board approved a total revised option pool of 1,30,98,000 stock options for ESOP 2026.The meeting was held on April 22, 2026, and commenced at 11:30 a.m.
For details on the appointments, the following table summarizes the professional profiles:
| Director Name | Designation | Affiliation | Key Experience Highlights |
|---|---|---|---|
| Mr. Amit Jain | Additional Director (Non-Executive, Non-Independent) | Carlyle group | Partner and Head of Carlyle India Advisors. Expertise in private equity and industry experience, specializing in buyout investments. |
| Mr. Abhiroop Jayanthi | Additional Director (Non-Executive, Non-Independent) | Carlyle group | Managing Director, Asia Private Equity team at Carlyle. Focus on investments in healthcare, life sciences, and advanced manufacturing. |
VIYASH Stock Price Movement
Shares of Viyash Scientific Limited are edging higher to ₹209.01 as of 12:49 PM today, gaining 0.46% in live trading. The equity has seen robust interest, trading over 356,332 shares and currently operating within an intraday range of ₹207 to ₹212.28.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.